Pursuant to the Regulation 24A of SEBI (LODR) Regulations, 2015, enclosed is the Annual Secretarial Compliance Report for the year ended March 31, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Pharmaids Pharmaceuticals Limited has filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026, certified by Practicing Company Secretary Kashinath Sahu. The report examines compliance across 10 key areas including SEBI LODR, ICDR, SAST, Insider Trading, and Depositories Regulations. The company has achieved full compliance with all applicable SEBI regulations during the review period. No deviations, observations, or violations were reported. No actions were taken against the company by SEBI or stock exchanges. The company maintained proper secretarial standards, updated policies, website disclosures, document preservation, performance evaluations, related party transactions, and insider trading norms.
Clean compliance report signals strong corporate governance and regulatory adherence, which is positive for shareholders and enhances investor confidence in the company's operational integrity.